We’re excited to announce a significant milestone for Riparian LLC. As of June 29, we have entered into an agreement to be acquired by Two Labs , a pharma services consulting company part of Envision Pharma Group and based in Columbus, Ohio. We’re truly excited for the union of Two Labs and Riparian. The services that Two Labs and Riparian provide are incredibly complementary and combining our capabilities will enable us to offer a broader and deeper suite of services to meet evolving client needs. Read more about the acquisition here: https://lnkd.in/g6Qmj5s #healthcare #pharma #consulting #innovation
Riparian LLC
制药业
Pasadena，CA 1,124 位关注者
Consulting, Outsourcing, and Software for the Life Sciences Industry
关于我们
Riparian is a solutions provider for the pharmaceuticals/life sciences industry, delivering software, managed services, and consulting services. We are a team of highly experienced pharmaceutical pricing and rebate analysts, business consultants, and engineers with a diverse range of backgrounds and skills. In an industry where regulations are on the rise, there is an ever-increasing need for a partner who can assist with strategic planning and evaluating their outcomes. Our depth and breadth of experience give us the ability to advise our clients with a laser focus on their objectives and key results. We empower our clients by delivering innovations that provide efficient, clear, and accelerated insights. As part of the global Envision Pharma Group family, we are proud to be backed by their best-in-class technology and artificial intelligence solutions, medical strategy, medical communications, publication planning & delivery, and patient engagement services, as well as offer access to their proprietary services through Okra.ai, Two Labs, and 90TEN.
- 网站
-
https://riparian.com
Riparian LLC的外部链接
- 所属行业
- 制药业
- 规模
- 51-200 人
- 总部
- Pasadena，CA
- 类型
- 私人持股
- 创立
- 2016
- 领域
- Management Consulting、Technology Consulting、Risk Consulting、Pharmaceutical Pricing、Pharmaceutical Contracting和Business Intelligence / Data Visualization
地点
Riparian LLC员工
动态
-
The Medicaid Drug Rebate Program (MDRP) Final Rule introduces significant updates that manufacturers must navigate to remain compliant. To help you address these changes effectively, Riparian, part of Two Labs (an Envision Pharma Group), has developed the Medicaid Final Rule Reference Guide. This guide provides: ? Key insights into the Final Rule’s provisions. ? Actionable recommendations for compliance and risk management. ? Practical tools for evaluating operational and financial impacts. Download your copy now to stay informed and ahead of the curve: https://lnkd.in/gSeC5nDf Riparian combines regulatory expertise and innovative solutions to support your compliance needs. Let us help you meet these new challenges with confidence. #MedicaidFinalRule #GovernmentPricing #PharmaCompliance
-